Brooktree Capital Management’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
2025
Q2
$399K Buy
2025
Q1
$407K Buy
2024
Q4
$650K Buy
2024
Q3
$536K Buy
2024
Q2
$1.1M Sell
2024
Q1
$2.01M Buy
2023
Q4
$1.09M Sell
2023
Q3
$1.97M Sell
2023
Q2
$761K Buy
2023
Q1
$397K Buy
2022
Q4
$239K Sell
2022
Q3
$907K Buy
2022
Q2
$759K Buy
2022
Q1
$1.02M Buy